维普中文期刊产品整合服务
50篇 您的检索式:作者名="KIPNES MS"
    题名 作者 年代 出处 被引量
1Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes 显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
2Effect of the dipeptidyl peptidase-4 inhibitor Sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes 显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
3Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitns: a randomized, placebocontrolled study显示文摘Kipnes MS Krosnick A Rendell MS Egan JW Mathisen AL Schneider RL Am J0,,:1
4Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes care2006,29,12:1
5Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glybufide monotherapy 显示文摘Pratley RE Kipnes MS Fleck PR 2009Diabetes Obes Metab2009,11,2:1
6Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic controll in patients with type 2 diabets mellitus: a randomized,placebo-controlled study显示文摘Kipnes MS Krosnick A Rendell MS 2001Am J Med2001,111,:1
7Year two assessment of fenofibric acid and moderate-dose statin combination:a phase3,open-label,extension study显示文摘Kipnes MS Roth EM Rhyne JM 2010Clin Drug Investig2010,30,1:1
8Effect of the dipeptidyl peptidase-f inhibitor sitagliptin as monotherapy on glycemic control in patients woth type 2 diabetes显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
9Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus:a randomized placebo-controlled study 显示文摘Kipnes MS Krosnick A Rendell MS 2001Am J Med2001,1111,:1
10Effect of the dipep-tidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemiccontrol in patients with type 2 diabetes 显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
11Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
12Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
13Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized , placebocontrolled study显示文摘Kipnes MS Krosnick A Rendell MS 2001Am J Med2001,111,10:1
14Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized placebo - controlled study显示文摘Kipnes MS Krosick A Rendell MS 2001Am Med2001,111,:1
15Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy onglycernie control in patients with type 2 diabetes显示文摘Asehner P Kipnes MS Luneeford JK 2006Diabetes Care2006,29,12:1
16Effect of thedipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes 显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
17Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus:a randomized,placebo-controlled study显示文摘Kipnes MS Krosnick A Rendell MS 2001Am J Med2001,111,1:1
18Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy 显示文摘Pratley RE Kipnes MS Fleck PR 2009Diabetes Obes Metab2009,11,2:1
19Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘Aschner P Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
20Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘 Kipnes MS Lunceford JK 2006Diabetes Care2006,29,12:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费